Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Protein S human is a vitamin K-dependent plasma glycoprotein that functions as a crucial natural anticoagulant in the human body. It acts as a non-enzymatic cofactor for Activated Protein C (APC), enhancing APC's ability to proteolytically inactivate procoagulant factors Va and VIIIa, thereby regulating blood clot formation. Additionally, Protein S serves as a cofactor for Tissue Factor Pathway Inhibitor (TFPI), accelerating the inhibition of Factor Xa. It also directly inhibits Factor IXa and Factor Xa. Beyond its anticoagulant roles, Protein S is involved in inflammation and efferocytosis by acting as a ligand for the TAM (Tyro-3, Axl, and Mer) family of protein kinase receptors. Therapeutic applications of Protein S, often as a component of combination products like prothrombin complex concentrates (PCCs) or as recombinant protein, are being investigated for managing bleeding disorders, reversing anticoagulation, and preventing thrombosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Protein S human.